Volume 13, Issue 4 (Autumn 2024)
aumj 2024, 13(4): 307-310 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Abbasi Khoshsirat N, Samimisedeh P. A 76-year-old patient with COVID-19 and cerebral hemorrhage. aumj 2024; 13 (4) :307-310
URL: http://aums.abzums.ac.ir/article-1-1204-en.html
URL: http://aums.abzums.ac.ir/article-1-1204-en.html
1- Cardiovascular Research Center, Alborz University of Medical Sciences, Karaj, Iran
2- Rajaei Clinical Research Development Unit,Alborz University of Medical Sciences, Karaj, Iran
2- Rajaei Clinical Research Development Unit,Alborz University of Medical Sciences, Karaj, Iran
Abstract: (598 Views)
In March 2020, the World Health Organization (WHO) announced that the disease caused by the SARS-COV-2 virus (COVID-19) is a pandemic. The initial symptoms of COVID-19 typically include fever, dry cough, and fatigue. Although cerebrovascular symptoms and strokes have also been mentioned as complications of COVID-19, the exact pathophysiology of these conditions is still not fully understood, and the route of virus entry into the nervous system remains unclear, with various hypotheses proposed. Regarding brain hemorrhage and its connection to COVID-19, a study raised the question of whether COVID-19 is the cause of this complication or merely a coincidence. It has been hypothesized that the angiotensin-converting enzyme 2 (ACE2) receptor, present in the endothelial cells of cerebral vessels and involved in vascular autoregulation and cerebral blood flow, may be affected by COVID-19, potentially leading to disturbances in cerebral autoregulation and ultimately resulting in the rupture of cerebral vessels. This case report presents a 76-year-old man with brain hemorrhage and concurrent COVID-19, confirmed by PCR testing.
Type of Study: Case Report |
Subject:
Special
Received: 2020/10/21 | Accepted: 2022/09/12 | Published: 2024/11/30
Received: 2020/10/21 | Accepted: 2022/09/12 | Published: 2024/11/30
References
1. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta bio-medica: Atenei Parmensis. 2020 Mar 19;91(1):157-60.
2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet 2020 Feb 15;395(10223):497-506. [DOI:10.1016/S0140-6736(20)30183-5. PMid:31986264]
3. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama 2020 Mar 17;323(11):1061-9. [DOI:10.1001/jama.2020.1585. PMid:32031570 PMCid:PMC7042881]
4. Wang HY, Li XL, Yan ZR, Sun XP, Han J, Zhang BW. Potential neurological symptoms of COVID-19. Therapeutic Advances in Neurological Disorders 2020 Mar;13:1756286420917830. [DOI:10.1177/1756286420917830. PMid:32284735 PMCid:PMC7119227]
5. Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dandu V, Toom S, Glaser A, Elsayegh D. COVID-19 presenting as stroke. Brain, behavior, and immunity 2020 Apr 28. [DOI:10.1016/j.bbi.2020.04.077. PMid:32360439 PMCid:PMC7187846]
6. Sharifi-Razavi A, Karimi N, Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental?. New microbes and new infections 2020 May;35. [DOI:10.1016/j.nmni.2020.100669. PMid:32322398 PMCid:PMC7163302]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
